These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Cholinesterase inhibitors: A new class of psychotropic compounds. Cummings JL Am J Psychiatry; 2000 Jan; 157(1):4-15. PubMed ID: 10618007 [TBL] [Abstract][Full Text] [Related]
6. Mechanism of action of cholinesterase inhibitors in Alzheimer's disease. Håkansson L Acta Neurol Scand Suppl; 1993; 149():7-9. PubMed ID: 7907455 [TBL] [Abstract][Full Text] [Related]
7. [Cholinergic treatment strategies in Alzheimer's disease]. Kurz A; Rüster P; Romero B; Zimmer R Nervenarzt; 1986 Oct; 57(10):558-69. PubMed ID: 3785472 [No Abstract] [Full Text] [Related]
8. [The cholinergic perspectives in the treatment of Alzheimer's disease: tacrine]. Royuela Rico A; Macías Fernández JA Rev Clin Esp; 1995 Jul; 195(7):473-8. PubMed ID: 7667523 [No Abstract] [Full Text] [Related]
9. [The pharmacotherapy of the cognitive disorders in Alzheimer's disease. Guidelines for rational drug use--a review]. Strnad J; Bahro M Dtsch Med Wochenschr; 2000 Jul; 125(27):835-9. PubMed ID: 10929539 [No Abstract] [Full Text] [Related]
10. New drug interventions in Alzheimer's disease. Stern GM Curr Opin Neurol Neurosurg; 1992 Feb; 5(1):100-3. PubMed ID: 1623227 [No Abstract] [Full Text] [Related]
11. [Drug therapy of Alzheimer's disease]. Sulkava R Duodecim; 2000; 116(24):2867-73. PubMed ID: 12077892 [No Abstract] [Full Text] [Related]
12. [Treatment of Alzheimer's disease]. Soininen H Duodecim; 1997; 113(18):1739-46. PubMed ID: 10892065 [No Abstract] [Full Text] [Related]
13. Cholinesterase inhibitors in the treatment of Alzheimer's disease and related dementias. Masterman D Clin Geriatr Med; 2004 Feb; 20(1):59-68. PubMed ID: 15062487 [No Abstract] [Full Text] [Related]
14. Novel cholinesterase inhibitors as future effective drugs for the treatment of Alzheimer's disease. Martinez A; Castro A Expert Opin Investig Drugs; 2006 Jan; 15(1):1-12. PubMed ID: 16370929 [TBL] [Abstract][Full Text] [Related]
15. Manipulation of the cholinergic system. Geroldi C; Bianchetti A; Trabucchi M Funct Neurol; 1997; 12(3-4):187-91. PubMed ID: 9218975 [No Abstract] [Full Text] [Related]
16. Efficacy of galantamine in probable vascular dementia and Alzheimer's disease combined with cerebrovascular disease: a randomized trial. Marder K Curr Neurol Neurosci Rep; 2002 Sep; 2(5):389-90. PubMed ID: 12169216 [No Abstract] [Full Text] [Related]
17. Cholinesterase inhibitors used in the treatment of Alzheimer's disease: the relationship between pharmacological effects and clinical efficacy. Wilkinson DG; Francis PT; Schwam E; Payne-Parrish J Drugs Aging; 2004; 21(7):453-78. PubMed ID: 15132713 [TBL] [Abstract][Full Text] [Related]
18. Pharmacotherapeutic approaches to the treatment of Alzheimer's disease. Standridge JB Clin Ther; 2004 May; 26(5):615-30. PubMed ID: 15220008 [TBL] [Abstract][Full Text] [Related]
20. Could the potential benefits of cholinesterase inhibitors in Alzheimer's disease be reduced after adjusting for coexisting diseases and multiple medications? Cheng HY J Gerontol A Biol Sci Med Sci; 2007 Jun; 62(6):680; author reply 680. PubMed ID: 17595429 [No Abstract] [Full Text] [Related] [Next] [New Search]